📗 Cite This Artifact
ERCC5 (XPG) Gene — Excision Repair Cross-Complementation Group 5
ERCC5 (XPG) Gene — Excision Repair Cross-Complementation Group 5
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">ERCC5 (XPG)</th></tr>
<tr><td><b>Full Name</b></td><td>Excision Repair Cross-Complementation Group 5 (XPG endonuclease)</td></tr>
<tr><td><b>Gene Symbol</b></td><td>ERCC5</td></tr>
<tr><td><b>Alternate Symbols</b></td><td>XPG, UV-DDB, UVSSP</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>13q33.2</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/6148" target="_blank">6148</a></td></tr>
<tr><td><b>OMIM</b></td><td><a href="https://www.omim.org/entry/133530" target="_blank">133530</a></td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000134899</td></tr>
<tr><td><b>UniProt ID</b></td><td><a href="https://www.uniprot.org/uniprotkb/Q15772" target="_blank">Q15772</a></td></tr>
<tr><td><b>Protein Length</b></td><td>1,186 amino acids</td></tr>
<tr><td><b>Category</b></td><td>DNA Repair/Nucleotide Excision Repair</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">22 edges</a></td>
</tr>
</table>
</div>
Overview
...
ERCC5 (XPG) Gene — Excision Repair Cross-Complementation Group 5
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">ERCC5 (XPG)</th></tr>
<tr><td><b>Full Name</b></td><td>Excision Repair Cross-Complementation Group 5 (XPG endonuclease)</td></tr>
<tr><td><b>Gene Symbol</b></td><td>ERCC5</td></tr>
<tr><td><b>Alternate Symbols</b></td><td>XPG, UV-DDB, UVSSP</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>13q33.2</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/6148" target="_blank">6148</a></td></tr>
<tr><td><b>OMIM</b></td><td><a href="https://www.omim.org/entry/133530" target="_blank">133530</a></td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000134899</td></tr>
<tr><td><b>UniProt ID</b></td><td><a href="https://www.uniprot.org/uniprotkb/Q15772" target="_blank">Q15772</a></td></tr>
<tr><td><b>Protein Length</b></td><td>1,186 amino acids</td></tr>
<tr><td><b>Category</b></td><td>DNA Repair/Nucleotide Excision Repair</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">22 edges</a></td>
</tr>
</table>
</div>
Overview
ERCC5 (Excision Repair Cross-Complementation Group 5), also known as XPG, is a critical DNA repair gene that encodes a structure-specific endonuclease essential for nucleotide excision repair (NER). The XPG protein plays a fundamental role in maintaining genomic integrity by excising bulky DNA adducts and UV-induced photoproducts that would otherwise cause mutations and cell death [@ncbi].
ERCC5 was originally identified through complementation studies in xeroderma pigmentosum (XP) patients, where fibroblasts from XP-G complementation group failed to perform NER. Subsequent research has revealed that ERCC5 deficiency causes not only XP but also Cockayne syndrome (CS) in compound heterozygotes, and is associated with a spectrum of neurodegenerative conditions including cerebellar ataxia, peripheral neuropathy, and accelerated aging phenotypes [@maddukuri2022].
The discovery of ERCC5 variants in neurodegenerative diseases beyond XP/CS has highlighted the broader importance of DNA repair capacity in maintaining neuronal health. With the aging population and increased prevalence of neurodegenerative disorders, understanding how ERCC5 and other DNA repair genes contribute to neuronal survival has become a critical area of research [@jacobs2015].
Protein Structure and Domains
XPG is a large protein (1,186 amino acids) with a modular domain architecture that enables its specialized endonuclease function:
| Domain | Location | Function |
|--------|----------|----------|
| N-terminal Region | 1-400 aa | Protein-protein interactions, regulatory functions |
| Nuclease Domain | 400-800 aa | Catalytic endonuclease activity |
| Helix-hairpin-helix (HhH) | 800-1000 aa | DNA binding, structural stability |
| Iron-sulfur cluster (4Fe-4S) | 950-1050 aa | DNA binding, structural |
| C-terminal Region | 1050-1186 aa | Interaction with TFIIH complex |
Catalytic Core
The catalytic core of XPG contains the active site responsible for DNA cleavage:
Structural Studies
High-resolution crystal structures have revealed the molecular basis of XPG's function:
- The nuclease domain adopts a structure similar to other flap endonucleases (FEN1) and resolvases
- The 4Fe-4S cluster stabilizes the protein and may act as a redox sensor
- Conformational changes upon DNA binding activate the nuclease activity [@muscroft2011]
Molecular Function
Nucleotide Excision Repair
XPG is a key component of the NER pathway, which removes bulky DNA lesions that distort the helix:
| NER Sub-pathway | Role of XPG |
|-----------------|-------------|
| Global Genome NER (GG-NER) | Scans DNA for lesions across the genome |
| Transcription-Coupled NER (TC-NER) | Removes lesions from actively transcribed genes |
| Dual incision | Makes 3' incision 6-8 nucleotides from lesion |
| DNA synthesis | Gap filling by polymerases δ, ε, κ |
| Ligation | Seals the repaired strand |
XPG-Mediated Incision
The specific incision reaction catalyzed by XPG:
Interaction Partners
XPG interacts with multiple proteins in the NER complex:
| Partner | Function | Interaction Domain |
|---------|----------|--------------------|
| XPC-RAD23B | Lesion recognition | N-terminal region |
| TFIIH | DNA unwinding | Central catalytic domain |
| XPA | Damage verification | C-terminal region |
| XPF-ERCC1 | 5' incision partner | Direct protein interaction |
| RPA | Single-strand binding | Competitive binding |
| PCNA | Replication clamp | C-terminal interaction |
Role in Neurodegeneration
DNA Damage in the Brain
Neurons face unique challenges regarding DNA damage:
- High metabolic demand: Reactive oxygen species (ROS) from mitochondrial respiration cause oxidative DNA damage
- Long lifespan: Neurons must maintain genomic integrity for decades without cell division
- Post-mitotic nature: Unlike other cells, neurons cannot dilute DNA damage through cell division
- Transcriptionally active: High rates of transcription create abundant opportunities for transcription-coupled repair failures [@brooks2013]
Evidence from Model Systems
Studies in mice and cellular models demonstrate the importance of XPG in neuronal health:
- XPG knockout mice: Show accelerated neurodegeneration, particularly in the cerebellum
- Conditional knockouts: Neural-specific XPG deletion causes progressive motor deficits
- Reduced neurogenesis: XPG-deficient mice show impaired hippocampal neurogenesis
- Accelerated aging: Phenotypic features of premature aging in nervous system [@andressoo2011]
Oxidative Stress Connection
XPG plays a critical role in repairing oxidative DNA damage:
- 8-oxoguanine (8-oxoG) lesions are repaired through base excision repair, but when present in bulky contexts, NER contributes
- XPG deficiency leads to accumulation of oxidative lesions in neurons
- Mitochondrial DNA is particularly vulnerable and requires NER activity [@calkins2013]
Genetic Evidence for Disease Association
Xeroderma Pigmentosum (XP)
XP is an autosomal recessive disorder characterized by:
| Feature | Description |
|---------|-------------|
| Sunlight sensitivity | Extreme UV sensitivity leading to sunburn |
| Pigmentation changes | Freckling, hyperpigmentation in sun-exposed areas |
| Cancer predisposition | 10,000-fold increased risk of skin cancers |
| Neurological degeneration | Progressive neurodegeneration in many patients |
XP-G patients have biallelic ERCC5 mutations that result in partial or complete loss of nuclease activity. Genotype-phenotype correlations show that mutations preserving some catalytic activity lead to milder phenotypes [@lehmann1995].
Cockayne Syndrome (CS)
Compound heterozygous ERCC5 mutations can cause features of Cockayne syndrome:
- Growth failure: Postnatal growth retardation
- Neurological impairment: Intellectual disability, motor deficits
- Premature aging: Aged appearance, early onset of age-related conditions
- Sunlight sensitivity: CS patients are photosensitive but do not develop skin cancers at the same rate as XP
The CS phenotype suggests that XPG's role in transcription-coupled repair is particularly important for neuronal function [@maddukuri2022].
Neurodegenerative Diseases Without XP
Beyond classic DNA repair disorders, ERCC5 variants have been implicated in:
| Disease | Evidence | Mechanism |
|---------|----------|-----------|
| Alzheimer's disease | GWAS signals, expression changes | Impaired DNA repair capacity |
| Parkinson's disease | Rare variants, reduced expression | Mitochondrial DNA damage accumulation |
| Amyotrophic lateral sclerosis | Rare coding variants | Cumulative DNA damage |
| Ataxia | Autosomal recessive variants | Cerebellar neuron loss |
Disease Mechanisms
Accumulation of DNA Damage
The primary disease mechanism in ERCC5 deficiency:
Impact on Neuronal Function
DNA damage accumulation affects neurons through multiple pathways:
- Transcriptional dysfunction: Impaired gene expression disrupts neuronal homeostasis
- Metabolic crisis: Loss of mitochondrial gene expression affects energy production
- Proteostatic stress: Accumulated damage triggers unfolded protein response
- Inflammation: DNA damage signaling activates neuroinflammatory pathways [@schaerer2015]
Compensatory Mechanisms
Cells and organisms have attempted compensatory responses:
- Cell cycle arrest: p53-mediated arrest allows time for repair
- Apoptosis: Eliminates severely damaged cells
- Senescence: Irreversible cell cycle exit
- Deregulation of differentiation: Stem cell pools are affected
The balance between these responses determines whether XPG-deficient cells survive or die [@hoeijmakers2009].
Therapeutic Implications
Gene Therapy Approaches
Given that ERCC5 deficiency is caused by loss-of-function mutations, gene replacement is a logical therapeutic approach:
| Strategy | Status | Challenge |
|----------|--------|-----------|
| AAV vectors | Preclinical | Delivery to neurons, expression levels |
| CRISPR-based correction | Research | Repair efficiency, off-target effects |
| mRNA delivery | Discovery | Delivery, duration of expression |
| Protein therapy | Preclinical | BBB penetration, stability |
Small Molecule Enhancers
DNA repair capacity can potentially be enhanced pharmacologically:
- Poly(ADP-ribose) polymerase (PARP) inhibitors: Paradoxically, inhibition can be protective in some contexts
- DNA repair facilitators: Compounds that promote repair complex assembly
- Antioxidants: Reduce oxidative DNA damage burden
- Neuroprotective agents: Support neuronal survival during repair deficiency
Challenges and Considerations
Several challenges face therapeutic development:
Interaction Network
ERCC5/XPG interacts with multiple proteins relevant to neurodegeneration:
| Interactor | Function | Relevance |
|------------|----------|-----------|
| XPC (RAD23B) | Global genome NER | Lesion recognition |
| TFIIH complex | Transcription/repair | DNA unwinding |
| XPA | Damage verification | Damage site selection |
| XPF-ERCC1 | 5' incision | Complementary incision |
| RPA | Single-strand protection | Prevents further damage |
| PCNA | Replication clamp | DNA synthesis |
| p53 | DNA damage response | Cell fate decisions |
| ATR | Replication stress response | Checkpoint activation |
Expression Pattern
Brain Expression
ERCC5 shows differential expression across brain cell types:
| Cell Type | Expression Level | Notes |
|-----------|-----------------|-------|
| Neurons | High | Active transcription requires robust repair |
| Astrocytes | Moderate | Support cells with DNA repair capacity |
| Microglia | Moderate | Immune cells with DNA damage response |
| Oligodendrocytes | Moderate | Myelinating cells |
| Neural stem cells | Very High | Active proliferation requires repair |
Developmental Regulation
ERCC5 expression changes during development:
- Highest expression during embryonic neurogenesis
- Maintained high in postnatal and adult brain
- Upregulated in response to DNA damage
- Age-related decline may contribute to neurodegeneration [@schlatter2019]
Comparison with Other DNA Repair Genes
| Gene | Primary Function | ERCC5 Relationship |
|------|-----------------|--------------------|
| ERCC1 | 5' incision in NER | Direct partner in NER |
| XPC | Lesion recognition | Initiates GG-NER |
| XPA | Damage verification | Coordinates repair |
| XPD (ERCC2) | TFIIH helicase | Part of same complex |
| XPF | 5' incision | Partner endonuclease |
| OGG1 | Base excision repair | Complementary pathway |
| TDP1 | Repair of topoisomerase lesions | Separate repair pathway |
Key Publications
See Also
- [DNA Repair Mechanisms](/mechanisms/dna-repair-pathways) — Pathway overview
- [Nucleotide Excision Repair](/mechanisms/nucleotide-excision-repair) — NER mechanism
- [Xeroderma Pigmentosum](/diseases/xeroderma-pigmentosum) — Related disease
- [Cockayne Syndrome](/diseases/cockayne-syndrome) — Related disease
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Neurodegeneration
- [Parkinson's Disease](/diseases/parkinsons-disease) — Neurodegeneration
- [Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration) — Related mechanism
External Links
- [NCBI Gene: ERCC5](https://www.ncbi.nlm.nih.gov/gene/6148)
- [UniProt: XPG](https://www.uniprot.org/uniprotkb/Q15772)
- [Ensembl: ERCC5](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134899)
- [OMIM: ERCC5](https://www.omim.org/entry/133530)
- [GWAS Catalog: ERCC5](https://www.ebi.ac.uk/gwas/genes/ERCC5)
Brain Atlas Resources
- [Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=ERCC5) — Gene expression data
- [BrainSpan](https://brainspan.org/) — Developmental transcriptome
- [Human Protein Atlas](https://www.proteinatlas.org/ENSG00000134899-ERCC5) — Protein expression
Pathway Diagram
The following diagram shows the key molecular relationships involving xpg discovered through SciDEX knowledge graph analysis:
Pathway Diagram
The following diagram shows the key molecular relationships involving ERCC5 (XPG) Gene — Excision Repair Cross-Complementation Group 5 discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-xpg |
| kg_node_id | XPG |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-227e5c0ad3b3 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-xpg'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-xpg?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[ERCC5 (XPG) Gene — Excision Repair Cross-Complementation Group 5](http://scidex.ai/artifact/wiki-genes-xpg)
http://scidex.ai/artifact/wiki-genes-xpg